TrialBMC cancer2026

Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia.

Wanqi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.